ASX - By Stock
|
EUR Lithium |
Re:
General Discussion
|
|
jefferies2
|
1.3K |
397K |
0 |
29/02/24 |
29/02/24 |
ASX - By Stock
|
1.3K
|
397K
|
0
|
|
ASX - By Stock
|
EUR |
Re:
Ann: Voluntary Suspension Extension
|
|
jefferies2
|
38 |
12K |
2 |
29/02/24 |
29/02/24 |
ASX - By Stock
|
38
|
12K
|
2
|
|
ASX - By Stock
|
EUR |
Re:
Ann: Voluntary Suspension Extension
|
|
jefferies2
|
38 |
12K |
1 |
29/02/24 |
29/02/24 |
ASX - By Stock
|
38
|
12K
|
1
|
|
ASX - By Stock
|
EUR Lithium |
Re:
General Discussion
|
|
jefferies2
|
1.3K |
397K |
4 |
29/02/24 |
29/02/24 |
ASX - By Stock
|
1.3K
|
397K
|
4
|
|
ASX - By Stock
|
EUR |
Re:
Ann: Voluntary Suspension Extension
|
|
jefferies2
|
38 |
12K |
2 |
29/02/24 |
29/02/24 |
ASX - By Stock
|
38
|
12K
|
2
|
|
ASX - By Stock
|
PAA Biotech |
Re:
The Final Charge , Phase I/II MND Results & FDA ODD Approval Catalyst
|
|
jefferies2
|
1.4K |
365K |
4 |
29/02/24 |
29/02/24 |
ASX - By Stock
|
1.4K
|
365K
|
4
|
|
ASX - By Stock
|
PAA Biotech |
Re:
The Final Charge , Phase I/II MND Results & FDA ODD Approval Catalyst
|
|
jefferies2
|
1.4K |
365K |
7 |
29/02/24 |
29/02/24 |
ASX - By Stock
|
1.4K
|
365K
|
7
|
|
ASX - By Stock
|
EUR |
Re:
Ann: Voluntary Suspension Extension
|
|
jefferies2
|
38 |
12K |
4 |
29/02/24 |
29/02/24 |
ASX - By Stock
|
38
|
12K
|
4
|
|
ASX - By Stock
|
EUR Lithium |
Re:
General Discussion
|
|
jefferies2
|
1.3K |
397K |
4 |
28/02/24 |
28/02/24 |
ASX - By Stock
|
1.3K
|
397K
|
4
|
|
ASX - By Stock
|
PAA Biotech |
Re:
The Final Charge , Phase I/II MND Results & FDA ODD Approval Catalyst
|
|
jefferies2
|
1.4K |
365K |
5 |
28/02/24 |
28/02/24 |
ASX - By Stock
|
1.4K
|
365K
|
5
|
|
ASX - By Stock
|
EUR Lithium |
Re:
General Discussion
|
|
jefferies2
|
1.3K |
397K |
0 |
28/02/24 |
28/02/24 |
ASX - By Stock
|
1.3K
|
397K
|
0
|
|
ASX - By Stock
|
EUR Lithium |
Re:
General Discussion
|
|
jefferies2
|
1.3K |
397K |
1 |
28/02/24 |
28/02/24 |
ASX - By Stock
|
1.3K
|
397K
|
1
|
|
ASX - By Stock
|
EUR Lithium |
Re:
General Discussion
|
|
jefferies2
|
1.3K |
397K |
0 |
27/02/24 |
27/02/24 |
ASX - By Stock
|
1.3K
|
397K
|
0
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Investor webinar - Phase 1 MND Study Top-Line Results
|
|
jefferies2
|
209 |
51K |
6 |
27/02/24 |
27/02/24 |
ASX - By Stock
|
209
|
51K
|
6
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Investor webinar - Phase 1 MND Study Top-Line Results
|
|
jefferies2
|
209 |
51K |
11 |
27/02/24 |
27/02/24 |
ASX - By Stock
|
209
|
51K
|
11
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Investor webinar - Phase 1 MND Study Top-Line Results
|
|
jefferies2
|
209 |
51K |
3 |
27/02/24 |
27/02/24 |
ASX - By Stock
|
209
|
51K
|
3
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Investor webinar - Phase 1 MND Study Top-Line Results
|
|
jefferies2
|
209 |
51K |
2 |
27/02/24 |
27/02/24 |
ASX - By Stock
|
209
|
51K
|
2
|
|
ASX - By Stock
|
EUR Lithium |
Re:
General Discussion
|
|
jefferies2
|
1.3K |
397K |
0 |
27/02/24 |
27/02/24 |
ASX - By Stock
|
1.3K
|
397K
|
0
|
|
ASX - By Stock
|
EUR Lithium |
Re:
General Discussion
|
|
jefferies2
|
1.3K |
397K |
3 |
27/02/24 |
27/02/24 |
ASX - By Stock
|
1.3K
|
397K
|
3
|
|
ASX - By Stock
|
EUR |
Re:
Ann: Voluntary Suspension Extension
|
|
jefferies2
|
19 |
7.1K |
0 |
26/02/24 |
26/02/24 |
ASX - By Stock
|
19
|
7.1K
|
0
|
|
ASX - By Stock
|
EUR |
Re:
Ann: Voluntary Suspension Extension
|
|
jefferies2
|
19 |
7.1K |
2 |
26/02/24 |
26/02/24 |
ASX - By Stock
|
19
|
7.1K
|
2
|
|
ASX - By Stock
|
EUR Lithium |
Re:
General Discussion
|
|
jefferies2
|
1.3K |
397K |
1 |
25/02/24 |
25/02/24 |
ASX - By Stock
|
1.3K
|
397K
|
1
|
|
ASX - By Stock
|
ETM |
Re:
Dissatisfaction and early election talk
|
|
jefferies2
|
22 |
5.3K |
1 |
23/02/24 |
23/02/24 |
ASX - By Stock
|
22
|
5.3K
|
1
|
|
ASX - By Stock
|
EUR |
Re:
Sizzle Approves Merger
|
|
jefferies2
|
47 |
21K |
7 |
23/02/24 |
23/02/24 |
ASX - By Stock
|
47
|
21K
|
7
|
|
ASX - By Stock
|
EUR |
Re:
Ann: Voluntary Suspension Extension
|
|
jefferies2
|
123 |
40K |
2 |
20/02/24 |
20/02/24 |
ASX - By Stock
|
123
|
40K
|
2
|
|
ASX - By Stock
|
EUR |
Re:
Ann: Appendix 3Y - Tony Sage
|
|
jefferies2
|
7 |
4.3K |
2 |
20/02/24 |
20/02/24 |
ASX - By Stock
|
7
|
4.3K
|
2
|
|
ASX - By Stock
|
EUR |
Re:
Ann: Voluntary Suspension Extension
|
|
jefferies2
|
123 |
40K |
4 |
20/02/24 |
20/02/24 |
ASX - By Stock
|
123
|
40K
|
4
|
|
ASX - By Stock
|
EUR |
Re:
Ann: Suspension from Quotation
|
|
jefferies2
|
270 |
82K |
2 |
18/02/24 |
18/02/24 |
ASX - By Stock
|
270
|
82K
|
2
|
|
ASX - By Stock
|
EUR |
Re:
Ann: Suspension from Quotation
|
|
jefferies2
|
270 |
82K |
3 |
18/02/24 |
18/02/24 |
ASX - By Stock
|
270
|
82K
|
3
|
|
ASX - By Stock
|
ETM |
Re:
GoG/Danish Gov Defense
|
|
jefferies2
|
32 |
8.6K |
5 |
17/02/24 |
17/02/24 |
ASX - By Stock
|
32
|
8.6K
|
5
|
|
ASX - By Stock
|
ETM |
Re:
Does Greenland want to remain poor?
|
|
jefferies2
|
7 |
1.4K |
1 |
17/02/24 |
17/02/24 |
ASX - By Stock
|
7
|
1.4K
|
1
|
|
ASX - By Stock
|
EUR |
Re:
Ann: Suspension from Quotation
|
|
jefferies2
|
270 |
82K |
2 |
17/02/24 |
17/02/24 |
ASX - By Stock
|
270
|
82K
|
2
|
|
ASX - By Stock
|
ATC |
Re:
Ann: Altech - Investor Presentation
|
|
jefferies2
|
58 |
31K |
4 |
16/02/24 |
16/02/24 |
ASX - By Stock
|
58
|
31K
|
4
|
|
ASX - By Stock
|
ATC |
Re:
Ann: Altech - Investor Webinar Presentation
|
|
jefferies2
|
10 |
5.1K |
1 |
15/02/24 |
15/02/24 |
ASX - By Stock
|
10
|
5.1K
|
1
|
|
ASX - By Stock
|
EUR |
Re:
Ann: Critical Metals Corp. F-4 is Effective
|
|
jefferies2
|
362 |
109K |
3 |
15/02/24 |
15/02/24 |
ASX - By Stock
|
362
|
109K
|
3
|
|
ASX - By Stock
|
PAA |
Re:
Best ASX stock Pharmaust for the next 10 years
|
|
jefferies2
|
9 |
2.8K |
25 |
14/02/24 |
14/02/24 |
ASX - By Stock
|
9
|
2.8K
|
25
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Extension Study Begins, Analysis Suggests Survival Benefit
|
|
jefferies2
|
197 |
53K |
17 |
14/02/24 |
14/02/24 |
ASX - By Stock
|
197
|
53K
|
17
|
|
ASX - By Stock
|
EUR |
Re:
Ann: Suspension from Quotation
|
|
jefferies2
|
270 |
82K |
1 |
13/02/24 |
13/02/24 |
ASX - By Stock
|
270
|
82K
|
1
|
|
ASX - By Stock
|
EUR |
Re:
Ann: Suspension from Quotation
|
|
jefferies2
|
270 |
82K |
2 |
13/02/24 |
13/02/24 |
ASX - By Stock
|
270
|
82K
|
2
|
|
ASX - By Stock
|
EUR |
Re:
Ann: Suspension from Quotation
|
|
jefferies2
|
270 |
82K |
1 |
13/02/24 |
13/02/24 |
ASX - By Stock
|
270
|
82K
|
1
|
|
ASX - By Stock
|
EUR |
Re:
Ann: Suspension from Quotation
|
|
jefferies2
|
270 |
82K |
4 |
12/02/24 |
12/02/24 |
ASX - By Stock
|
270
|
82K
|
4
|
|
ASX - By Stock
|
ETM |
Re:
Ann: Further Update on Security for Costs
|
|
jefferies2
|
53 |
13K |
5 |
12/02/24 |
12/02/24 |
ASX - By Stock
|
53
|
13K
|
5
|
|
ASX - By Stock
|
ETM |
Re:
Ann: Further Update on Security for Costs
|
|
jefferies2
|
53 |
13K |
0 |
12/02/24 |
12/02/24 |
ASX - By Stock
|
53
|
13K
|
0
|
|
ASX - By Stock
|
EUR |
Re:
Ann: Suspension from Quotation
|
|
jefferies2
|
270 |
82K |
2 |
12/02/24 |
12/02/24 |
ASX - By Stock
|
270
|
82K
|
2
|
|
ASX - By Stock
|
EUR |
Re:
Ann: Suspension from Quotation
|
|
jefferies2
|
270 |
82K |
0 |
10/02/24 |
10/02/24 |
ASX - By Stock
|
270
|
82K
|
0
|
|
ASX - By Stock
|
EUR |
Re:
Ann: Suspension from Quotation
|
|
jefferies2
|
270 |
82K |
1 |
09/02/24 |
09/02/24 |
ASX - By Stock
|
270
|
82K
|
1
|
|
ASX - By Stock
|
PAA Biotech |
Re:
The Final Charge , Phase I/II MND Results & FDA ODD Approval Catalyst
|
|
jefferies2
|
1.4K |
365K |
4 |
08/02/24 |
08/02/24 |
ASX - By Stock
|
1.4K
|
365K
|
4
|
|
ASX - By Stock
|
EUR |
Re:
Ann: Suspension from Quotation
|
|
jefferies2
|
270 |
82K |
2 |
07/02/24 |
07/02/24 |
ASX - By Stock
|
270
|
82K
|
2
|
|
ASX - By Stock
|
EUR |
Re:
Ann: Suspension from Quotation
|
|
jefferies2
|
270 |
82K |
1 |
06/02/24 |
06/02/24 |
ASX - By Stock
|
270
|
82K
|
1
|
|
ASX - By Stock
|
EUR Lithium |
Re:
General Discussion
|
|
jefferies2
|
1.3K |
397K |
0 |
05/02/24 |
05/02/24 |
ASX - By Stock
|
1.3K
|
397K
|
0
|
|